Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH) Trial materials available to download

SARAH logo

The SARAH trial evaluated the clinical and cost effectiveness of a hand exercise programme for patients with Rheumatoid Arthritis of the hands, with positive results due to be published shortly.

The manual that describes the treatment programme developed for the SARAH trial is designed to guide the hand therapist through the SARAH exercise programme with detailed descriptions of the different elements. 

The aims of this manual are to: 

  • Provide the background and justification of the programme. 
  • Provide a procedural reference that explains what needs to be done to deliver the SARAH exercise programme in clinical practice. 

The manual and accompanying documents are now available to download. We are currently providing these materials freely, however we would like to collect details of who is using the materials and where and how they will be used.

 

For further information about the SARAH Trial or to download the SARAH Trial materials, see:
SARAH Trial page

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.